Skip to main content
. 2021 Jul 16;16:2119–2127. doi: 10.2147/COPD.S311236

Table 1.

Demographics, Lung Function and Symptoms of 264 Respiratory Outpatients with Bronchiectasis Followed for 5 Years at Two University Hospitals

Demographics N = 264a
Age (years) 66 (51–72)
Female 165 (62%)
BMI (kg/m2) 24.5 (21.8–27.1, N=226)
Smoking Status
 Never Smokers 112 (45%)
 Ex-Smokers 117 (47%)
 Current Smokers 22 (8.8%)
Pack-Years 15 (2–30, N=139)
BSI Score 6.0 (5.0–9.0, N=86)
COPD Diagnosis 65 (25%)
Asthma Diagnosis 72 (27%)
Aetiologiesb
 Allergic Bronchopulmonary Aspergillosis 15 (5.7%)
 Connective Tissue Disease 31 (12%)
 Inflammatory Bowel Disease 17 (6.7%)
 Childhood Severe Pulmonary Disease 30 (11%)
 Immunosuppression (Idiopathic and Pharmacologic) 12 (4.8%)
 Idiopathic Bronchiectasis 177 (67%)
Lung Function and Symptoms No ICS, N = 139 ICS-Treated, N = 122a p-valuec
FEV1 (L) 2.22 (1.79–2.80) (N=131) 1.71 (1.31–2.33) (N=118) <0.001
% Predicted 80.9 (71.2–93.1) (N=119) 65.2 (48.6–83.1) (N=104) <0.001
FVC 2.90 (2.42–3.48) (N=128) 2.56 (1.97–3.30) (N=116) 0.003
% Predicted 82.5 (68.8–89.6) (N=118) 75.2 (59.0–87.3) (N=104) 0.010
FEV1/FVC ratio 0.77 (0.71–0.81) (N=128) 0.70 (0.59–0.78) (N=116) <0.001
 >0.8 39 (30%) 22 (19%) 0.038
 <0.7 22 (17%) 59 (51%) <0.001
Chronic Cough 109 (71%, N=134) 103 (91%, N=113) 0.028
Chronic Sputum Production 91 (71%, N=129) 100 (89%, N=112) <0.001
Chronic Dyspnoea 43 (34%, N=126) 68 (64%, N=107) <0.001
Chronic Sinusitis 8 (7.6%, N=105) 6 (8.7%, N=69) 0.8

Notes: aStatistics presented: median (interquartile range); n (%). N denotes number of patients with data available. bSum >100% due to multiple possible aetiologies per patient. cStatistical tests performed: Wilcox test; chi-squared.

Abbreviations: BSI, Bronchiectasis Severity Index; COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity; ICS, inhaled corticosteroids.